Subscribe to this collection to receive daily e-mail notification of new additions

	Title	Author(s)	Issue Date
	Reappraisal of CheckMate-459 and Managing Adverse Events with Immune Checkpoint Inhibitors Proceeding/Conference:COSMIC 312 Investigator Meeting, ESMO 2019, Barcelona, Spain	Yau, TCC	2019
	Standard-of-Care for Lupus Nephritis – a preview of the forthcoming KDIGO guidelines Proceeding/Conference:2020 Renji Autoimmune Disease Forum (virtual meeting),	Chan, DTM	2020
	Lupus nephritis management – NIH, Euro-Lupus, MMF, and beyond Proceeding/Conference:International CME on Glomerular Diseases, Indian Society of Nephrology and Sanjay Gandhi Postgraduate Institute of Medical Sciences	Chan, DTM	2019
	The Evolving Paradigm of Asthma Management Proceeding/Conference:Global Initiative for Asthma (GINA) 2020 virtual expert meeting	Ip, MSM	2020
	Beta-lactam allergy: Factors predicting allergies and prevalence in Hong Kong Proceeding/Conference:Hong Kong College of Physicians and Royal College of Physicians Joint Scientific Meeting 2019	Li, PH	2019
	Beta-lactam Allergy in Chinese Patients and Factors Predicting Genuine Allergy Proceeding/Conference:Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) 2021 International Conference	Li, PH	2021
	Obstructive sleep apnea - does it matter? Proceeding/Conference:ISRD (International Society for Respiratory Disease) & ATS (American Thoracic Society) Joint Conference, 2019	Ip, MSM	2019
	Phenotyping in OSA Proceeding/Conference:2019 Annual Meeting of Sleep Medicine, Guangzhou	Ip, MSM	2019
	Declaring the New Chapter of Diabetes Management. Proceeding/Conference:Annual Scientific Meeting of Macau Physician Society: Advances in Medicine 2019	Lee, CHP	2019
	Health impact of obstructive sleep apnoea (OSA) - what we know and what we still do not know Proceeding/Conference:10th Annual Scientific Meeting of Macau Physician Society, 2019	Ip, MSM	2019
	Perspectives on clinical and research developments in sleep disordered breathing Proceeding/Conference:2019 Annual Congress of Chinese Thoracic Society	Ip, MSM	2019
	Should SGLT-2 inhibitors be used in every patient with diabetes mellitus? Proceeding/Conference:Hong Kong Society of Endocrinology, Metabolism and Reproduction Symposium, 2019	Siu, DCW	2019
	-		-
	Journey of Hereditary Angioedema in Hong Kong Proceeding/Conference:Plasma Protein Industry Summit	Li, PH	2020
	A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis Proceeding/Conference:Blood	Singh, GHHYacoub, APettit, KMBradley, TGerds, ATTatarczuch, MShortt, JCurtin, NJRossetti, JMBurbury, KMead, AJGöthert, JRKoschmieder, SJones, APeppe, JNatsoulis, GHong, WJStevenson, WSEwing, JHarrison, CNVannucchi, AWatts, JRoss, DMTalpaz, MRienhoff, HY	2021
	ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis Proceeding/Conference:Blood	Au Yeung, KHRRussel, VChoi, WLWong, ATsui, LLee, YYCLi, JSingh, GHHIp, HWKwong, YLDave, TOndrejka, SLBhagat, GChadburn, ARutherford, SCKoff, JLJaye, DLCzader, MLouissaint, ALi, SXu, JYin, CCOng, CKCheng, CLBehdad, AEvens, AMNorgaard, PHGang, AOLeppa, SKarjalainen-Lindsberg, MLChapman, JRAmador, CIqbal, JFedoriw, YBogusz, AMEvans, AGJuskevicius, RHsi, EDNaresh, KNDave, SSTse, EWC	2021
	Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia Proceeding/Conference:Blood	Mesa, RAKomatsu, NSingh, GHHJin, JLee, SEHou, HASato, TQin, AUrbanski, RShih, WZagrijtschuk, CZimmerman, CVerstovsek, S	2021
	S-ICD: Present and Future Proceeding/Conference:APHRS (Asia-Pacific Heart Rhythm Society) Scientific Session, 2021	Tse, HF	2021
	Development and Validation of the ACP-CAT for Assessing the Quality of Advance Care Planning Communication. Proceeding/Conference:Annual Assembly of Hospice and Palliative Care	Yuen, JKYKelley, ASGelfman, LPLindenberger, EESmith, CBArnold, RMCalton, BSchell, JBerns, SH	2021
	Longitudinal circulating tumor DNA (ctDNA) analysis in the phase 1b MONALEESASIA study of ribociclib (RIB) + endocrine therapy (ET) in Asian patients (pts) with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC) Proceeding/Conference:Annals of Oncology	Yap, YSSu, FJoshi, /MChiu, WYJMasuda, NIto, YIshikawa, TAruga, TKim, SJDeore, UBabbar, NBalbin, A	2021